由于其在肝细胞癌中的致癌作用,WDR74作为一种新的治疗点
Feng Gao1, Hui Zhou2, Xiaosong Huang3
1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, China; NHC Key Laboratory of Combined Multi-organ Transplantation, China; Key Laboratory of the diagnosis and treatment of organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), China; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Zhejiang Province, Hangzhou 310003, China.
在肝细胞癌 (HCC) 中,WD重复含有蛋白74 (WDR74) 的上调,与生存率差相关. 向WDR74可能会抑制HCC细胞增殖,并为这种耐火性癌症提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肝细胞癌 (HCC) 仍然是一个具有挑战性的恶性瘤.
- 在HCC瘤发生过程中,WD重复含蛋白74 (WDR74) 的作用尚不清楚.
研究的目的:
- 研究WDR74在HCC中的临床意义和生物功能.
- 评估WDR74作为预后生物标志物和HCC的潜在治疗标.
主要方法:
- 使用TCGA,GEO和UALCAN数据库进行生物信息分析.
- 通过qRT-PCR,西部斑块和免疫组织化学进行表达分析.
- 在体外实验中评估WDR74对HCC细胞增殖和细胞周期的影响.
主要成果:
- 在HCC组织中,WDR74表达显著升高.
- 较高的WDR74水平与HCC患者不良的整体存活率 (OS) 相相关.
- 通过影响细胞周期进展和诱导亡,WDR74 Knockdown 抑制了 HCC 细胞的增殖.
结论:
- 升高的WDR74表达是HCC中不良结果的预后指标.
- WDR74与HCC细胞增殖有关,是潜在的治疗点.
相关概念视频
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...


